Insider Transactions in Q1 2023 at Cin Cor Pharma, Inc. (CINC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2023
|
5 Am Partners Vi, LLC > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,937,646
-100.0%
|
-
|
|
Feb 24
2023
|
James Healy Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
6,073,949
-100.0%
|
-
|
|
Feb 24
2023
|
James Healy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,608
-100.0%
|
-
|
|
Feb 24
2023
|
James Healy Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,803
-33.33%
|
-
|
|
Feb 24
2023
|
Mason Freeman Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
100
-100.0%
|
-
|
|
Feb 24
2023
|
Mason Freeman Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-100.0%
|
-
|
|
Feb 24
2023
|
Mason Freeman Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,494
-5.87%
|
-
|
|
Feb 24
2023
|
Catherine Pearce Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,500
-100.0%
|
-
|
|
Feb 24
2023
|
Catherine Pearce Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
Feb 24
2023
|
Catherine Pearce Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
140,149
-90.33%
|
-
|
|
Feb 24
2023
|
Michael Wayne Kalb EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
202,437
-100.0%
|
-
|
|
Feb 24
2023
|
Marc De Garidel Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,000
-100.0%
|
-
|
|
Feb 24
2023
|
Marc De Garidel Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
12,500
-5.88%
|
-
|
|
Jan 26
2023
|
Michael Wayne Kalb EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177,000
+46.65%
|
-
|
|
Jan 26
2023
|
Catherine Pearce Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+8.82%
|
-
|
|
Jan 26
2023
|
Marc De Garidel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+48.48%
|
-
|
|
Jan 26
2023
|
Mason Freeman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+48.48%
|
-
|
|
Jan 11
2023
|
Catherine Pearce Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,997
-2.77%
|
$111,916
$28.75 P/Share
|
|
Jan 11
2023
|
Catherine Pearce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,235
+8.41%
|
-
|